You are viewing: Sweden Latent TB Testing Market analysis
Part of: Latent TB Testing Market (Global)

The Sweden Latent TB Testing Market was valued at $1.84 Million in 2024 and projected to reach to $2.25 Million by 2029, representing a compound annual growth rate of 4.0%. Sweden's latent TB testing market is positioned for steady expansion through 2029, supported by the country's commitment to preventive healthcare and robust public health infrastructure.

Sweden Latent TB Testing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Sweden Latent TB Testing Market Trends and Insights

  • Sweden's robust healthcare infrastructure and strong public health initiatives support steady demand for latent tuberculosis infection (LTBI) diagnostics.
  • The Swedish healthcare system's emphasis on preventive medicine and early detection drives adoption of advanced testing methodologies across clinical and occupational health settings. The growth trajectory in Sweden reflects increasing awareness of latent TB among healthcare professionals and at-risk populations, coupled with improved access to diagnostic technologies.
  • Sweden's commitment to tuberculosis elimination aligns with WHO targets, positioning the country as a leader in LTBI management within Europe.
  • Between 2024 and 2029, Sweden's market expansion will be supported by healthcare investments, regulatory support for TB screening programs, and integration of newer testing platforms into standard clinical practice..

Key Market Statistics

  • CAGR (2024-2029) 4.0% CAGR
  • Market Size, 2024 ~USD 1.84 Million
  • Forecast, 2029 ~USD 2.25 Million
  • Country Sweden

Sweden Latent TB Testing Market Overview

Market Valuation :

Sweden's latent TB testing market reached $1.84 million in 2024, with projected growth to $2.25 million by 2029, driven by preventive healthcare priorities and early detection initiatives.

Healthcare Infrastructure :

Sweden's advanced and well-funded healthcare system prioritizes preventive medicine and infectious disease screening, creating consistent demand for LTBI diagnostic solutions across public and private sectors.

Public Health Focus :

Strong Swedish public health initiatives and TB control programs emphasize early identification of latent infections, supporting steady adoption of modern testing technologies and diagnostic methods.

Growth Trajectory :

With a 4.0% CAGR through 2029, Sweden's market demonstrates stable, sustainable growth aligned with Nordic healthcare modernization and increased investment in infectious disease prevention.

Sweden Latent TB Testing Market Dynamics

  • The Swedish healthcare system's emphasis on early detection and infection control drives consistent demand for LTBI diagnostics among healthcare providers, occupational health services, and immigration screening programs.
  • Increasing awareness of tuberculosis risks and integration of advanced testing technologies into clinical workflows will further support market growth.
  • The market's 4.0% CAGR reflects Sweden's mature healthcare environment and the nation's proactive approach to infectious disease management, positioning it as a stable market for diagnostic providers..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Sweden's latent TB testing market is valued at $1.84 million in 2024 with projected growth to $2.25 million by 2029.
    • Sweden demonstrates a moderate 4.0% CAGR, reflecting steady healthcare investment and preventive medicine focus.
    • Sweden's advanced healthcare system and TB elimination commitment drive consistent demand for LTBI diagnostics.
    • Sweden's market growth is supported by regulatory frameworks, occupational health screening, and clinical integration of modern testing technologies.

    Latent TB Testing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment HOUSEHOLD CONTACTS WITH PULMONARY TB (Application)
    Forecast Period 2024-2029
    Growth Rate CAGR of 5.8% from 2024 to 2029
    Largest Segment IGRA (Test Type)
    Market Size Base Year (Billions) ~USD 0.58 (2024)
    Revenue Forecast (Billions) ~USD 0.77 (2029)
    Segments Covered Test Type, Application, End User

    Sweden Latent TB Testing Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Test Type

    • Igra
    • Tst

    By Application

    • Household Contacts With Pulmonary Tb
    • Other Applications
    • People Living With Hiv

    By End User

    • Academic & Research Institutes
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Other End Users

    SWEDEN: LATENT TB TESTING MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    ACADEMIC & RESEARCH INSTITUTES0.130.150.150.150.150.150.160.172.2
    DIAGNOSTIC LABORATORIES1.151.321.351.391.441.51.581.674.4
    HOSPITALS & CLINICS0.420.470.470.480.490.50.520.542.8
    OTHER END USERS0.060.070.070.070.070.070.070.081.7
    TOTAL1.762.012.042.082.152.232.342.463.8

    Target Audience

    • Diagnostic Device Manufacturers : Evaluate market entry strategies and product positioning for latent TB testing solutions in Sweden's healthcare system, identifying adoption barriers and growth opportunities.
    • Healthcare Investors : Assess investment potential in Swedish diagnostic companies and healthcare providers serving the LTBI testing market with reliable market sizing and growth projections.
    • Public Health Authorities : Utilize market data to inform TB prevention program planning, budget allocation, and diagnostic infrastructure development across Swedish healthcare regions.
    • Clinical Laboratory Operators : Understand market demand, competitive landscape, and service expansion opportunities for latent TB testing within Sweden's laboratory and diagnostic services sector.
    • Healthcare Consultants : Support client advisory services with Sweden-specific market intelligence for healthcare strategy, market analysis, and Nordic region expansion planning.

    Reasons to Buy this Report

    • Market-Specific Sizing : Access precise valuation data for Sweden's latent TB testing market with verified 2024 baseline ($1.84M) and 2029 forecasts ($2.25M), enabling accurate business planning and investment decisions.
    • Nordic Healthcare Insights : Understand Sweden's unique healthcare landscape, preventive medicine priorities, and public health initiatives that differentiate the Nordic market from global TB testing trends.
    • Growth Opportunity Assessment : Evaluate the 4.0% CAGR trajectory against global benchmarks (5.8%) to identify localized growth drivers, market saturation levels, and expansion opportunities specific to Swedish healthcare sectors.
    • Competitive Positioning : Develop Sweden-focused market entry strategies and competitive positioning by understanding local healthcare provider preferences, regulatory requirements, and diagnostic adoption patterns.
    • Strategic Planning : Support investment decisions, partnership development, and resource allocation for Swedish healthcare markets with country-specific data on market dynamics and forecast reliability.

    Frequently asked questions

    What is the current size of Sweden's latent TB testing market?

    Sweden's latent TB testing market was valued at $1.84 million in 2024 and is expected to reach $2.25 million by 2029.

    What is the projected growth rate for latent TB testing in Sweden?

    Sweden's latent TB testing market is projected to grow at a compound annual growth rate (CAGR) of 4.0% from 2024 to 2029.

    What factors drive latent TB testing demand in Sweden?

    Sweden's demand for latent TB testing is driven by its advanced healthcare infrastructure, preventive medicine focus, occupational health screening requirements, and commitment to WHO tuberculosis elimination targets.

    How does Sweden's market compare to other European countries?

    Sweden's 4.0% CAGR reflects a stable, mature healthcare market with consistent investment in TB diagnostics and strong regulatory support for screening programs across clinical and occupational settings.

    Which testing technologies are most prevalent in Sweden?

    Sweden's market utilizes both interferon-gamma release assays (IGRAs) and tuberculin skin tests (TSTs), with increasing adoption of newer molecular and immunological diagnostic platforms in clinical practice.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size for the latent TB testing market. Exhaustive secondary research was done to collect information on the latent TB testing industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the latent TB testing market.

    The four steps involved in estimating the market size are

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

    The following is a breakdown of the primary respondents:

    Note 1: Others include sales managers, marketing managers, and product managers.

    Note 2: Companies are classified into tiers based on their total revenues. As of 2022/2023, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.

    To know about the assumptions considered for the study, download the pdf brochure

    COMPANY NAME DESIGNATION
    QIAGEN General Manager
    Revvity Area Sales Manager

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the latent TB testing market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • The key players in the industry have been identified through extensive secondary research
    • The revenues generated by leading players operating in the latent TB testing market have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    The research methodology used to estimate the market size includes the following:

    Data Triangulation

    After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Latent tuberculosis testing refers to diagnosing the infection by detecting an immune response to Mycobacterium tuberculosis antigens using either the tuberculin skin test (TST) or interferon-gamma release assays (IGRAs). These tests help identify dormant tuberculosis infections in individuals without active symptoms.

    Stakeholders

    • Senior Management
    • End User
    • Finance/Procurement Department  
    • R&D Department

    Report Objectives

    • To define, describe, segment, and forecast the global latent TB testing market, by test type, application, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall latent TB testing market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Middle East & Africa, and Latin America
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
    • To benchmark players within the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product excellence

     

    Get the Full Latent TB Testing Market Report

    Full forecast, segment splits, and company analysis for all Latent TB Testing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status